GB9803446D0 - Measuring resistance to chemotherapeutic agents - Google Patents

Measuring resistance to chemotherapeutic agents

Info

Publication number
GB9803446D0
GB9803446D0 GBGB9803446.5A GB9803446A GB9803446D0 GB 9803446 D0 GB9803446 D0 GB 9803446D0 GB 9803446 A GB9803446 A GB 9803446A GB 9803446 D0 GB9803446 D0 GB 9803446D0
Authority
GB
United Kingdom
Prior art keywords
chemotherapeutic agents
measuring resistance
measuring
resistance
chemotherapeutic
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Withdrawn
Application number
GBGB9803446.5A
Other versions
GB2334577A (en
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
University of Liverpool
Original Assignee
University of Liverpool
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by University of Liverpool filed Critical University of Liverpool
Priority to GB9803446A priority Critical patent/GB2334577A/en
Publication of GB9803446D0 publication Critical patent/GB9803446D0/en
Priority to GB9814545A priority patent/GB2334579B/en
Priority to GB9903035A priority patent/GB2335739A/en
Priority to US09/622,577 priority patent/US6878526B1/en
Priority to AU26301/99A priority patent/AU2630199A/en
Priority to PCT/GB1999/000500 priority patent/WO1999042834A2/en
Priority to DE69907154T priority patent/DE69907154T2/en
Priority to EP99905083A priority patent/EP1057029B1/en
Priority to EP99905082A priority patent/EP1057028B1/en
Priority to CA002321467A priority patent/CA2321467A1/en
Priority to PCT/GB1999/000502 priority patent/WO1999042090A2/en
Priority to CA002321480A priority patent/CA2321480A1/en
Priority to JP2000532727A priority patent/JP2002504688A/en
Priority to CA002321458A priority patent/CA2321458A1/en
Priority to JP2000532728A priority patent/JP2002504354A/en
Priority to PCT/GB1999/000501 priority patent/WO1999042835A1/en
Priority to DE69907152T priority patent/DE69907152D1/en
Priority to JP2000532726A priority patent/JP2002504496A/en
Priority to AU25380/99A priority patent/AU739001B2/en
Priority to CA002321482A priority patent/CA2321482A1/en
Priority to PCT/GB1999/000512 priority patent/WO1999042839A2/en
Priority to EP99905081A priority patent/EP1057027A2/en
Priority to DE69907156T priority patent/DE69907156T2/en
Priority to DE69907151T priority patent/DE69907151D1/en
Priority to CA002321479A priority patent/CA2321479A1/en
Priority to AT99905086T priority patent/ATE238556T1/en
Priority to EP99905086A priority patent/EP1057031B1/en
Priority to AU25385/99A priority patent/AU753588B2/en
Priority to CA002321438A priority patent/CA2321438A1/en
Priority to EP99906326A priority patent/EP1057033B1/en
Priority to PCT/GB1999/000509 priority patent/WO1999042837A1/en
Priority to JP2000532719A priority patent/JP2002504353A/en
Priority to AU25379/99A priority patent/AU743454B2/en
Priority to AT99905082T priority patent/ATE238553T1/en
Priority to AU25384/99A priority patent/AU741632B2/en
Priority to JP2000532712A priority patent/JP2002504683A/en
Priority to AU26300/99A priority patent/AU749180B2/en
Priority to AT99906326T priority patent/ATE238558T1/en
Priority to CA002321481A priority patent/CA2321481A1/en
Priority to AT99905087T priority patent/ATE238557T1/en
Priority to AU25382/99A priority patent/AU741712B2/en
Priority to PCT/GB1999/000503 priority patent/WO1999042828A2/en
Priority to EP99905087A priority patent/EP1057032B1/en
Priority to DE69907155T priority patent/DE69907155T2/en
Priority to DE69907153T priority patent/DE69907153T2/en
Priority to AT99905084T priority patent/ATE238555T1/en
Priority to US09/622,277 priority patent/US6521407B1/en
Priority to PCT/GB1999/000506 priority patent/WO1999042821A2/en
Priority to JP2000532725A priority patent/JP2002504687A/en
Priority to JP2000532107A priority patent/JP2002503822A/en
Priority to PCT/GB1999/000505 priority patent/WO1999042836A1/en
Priority to AT99905083T priority patent/ATE238554T1/en
Priority to AU25381/99A priority patent/AU735896B2/en
Priority to EP99905084A priority patent/EP1057030B1/en
Publication of GB2334577A publication Critical patent/GB2334577A/en
Priority to US10/321,555 priority patent/US20030134315A1/en
Withdrawn legal-status Critical Current

Links

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/574—Immunoassay; Biospecific binding assay; Materials therefor for cancer
    • G01N33/57484—Immunoassay; Biospecific binding assay; Materials therefor for cancer involving compounds serving as markers for tumor, cancer, neoplasia, e.g. cellular determinants, receptors, heat shock/stress proteins, A-protein, oligosaccharides, metabolites
    • G01N33/57496—Immunoassay; Biospecific binding assay; Materials therefor for cancer involving compounds serving as markers for tumor, cancer, neoplasia, e.g. cellular determinants, receptors, heat shock/stress proteins, A-protein, oligosaccharides, metabolites involving intracellular compounds
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/18—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
    • C07K16/32—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against translation products of oncogenes

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Immunology (AREA)
  • Molecular Biology (AREA)
  • Cell Biology (AREA)
  • Engineering & Computer Science (AREA)
  • Urology & Nephrology (AREA)
  • Medicinal Chemistry (AREA)
  • Hematology (AREA)
  • Organic Chemistry (AREA)
  • Biomedical Technology (AREA)
  • Oncology (AREA)
  • General Health & Medical Sciences (AREA)
  • Biochemistry (AREA)
  • Physics & Mathematics (AREA)
  • Biotechnology (AREA)
  • Analytical Chemistry (AREA)
  • Food Science & Technology (AREA)
  • Hospice & Palliative Care (AREA)
  • General Physics & Mathematics (AREA)
  • Pathology (AREA)
  • Biophysics (AREA)
  • Genetics & Genomics (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Microbiology (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
GB9803446A 1998-02-18 1998-02-18 Resistance of p53 mutant cancer cells to cytoxic effects of (chemo)therapeutic agents involving assay of cyclin D1 protein Withdrawn GB2334577A (en)

Priority Applications (55)

Application Number Priority Date Filing Date Title
GB9803446A GB2334577A (en) 1998-02-18 1998-02-18 Resistance of p53 mutant cancer cells to cytoxic effects of (chemo)therapeutic agents involving assay of cyclin D1 protein
GB9814545A GB2334579B (en) 1998-02-18 1998-07-03 Treating cancer
GB9903035A GB2335739A (en) 1998-02-18 1999-02-10 Screening anti-cancer agents
US09/622,577 US6878526B1 (en) 1998-02-18 1999-02-18 Treating cancer
AU26301/99A AU2630199A (en) 1998-02-18 1999-02-18 Treating cancer
PCT/GB1999/000500 WO1999042834A2 (en) 1998-02-18 1999-02-18 Treating cancer
DE69907154T DE69907154T2 (en) 1998-02-18 1999-02-18 CANCER TREATMENT
EP99905083A EP1057029B1 (en) 1998-02-18 1999-02-18 Treating cancer
EP99905082A EP1057028B1 (en) 1998-02-18 1999-02-18 Treating cancer
CA002321467A CA2321467A1 (en) 1998-02-18 1999-02-18 Treating cancer
PCT/GB1999/000502 WO1999042090A2 (en) 1998-02-18 1999-02-18 Treating cancer
CA002321480A CA2321480A1 (en) 1998-02-18 1999-02-18 Treating cancer
JP2000532727A JP2002504688A (en) 1998-02-18 1999-02-18 Cancer Treatment
CA002321458A CA2321458A1 (en) 1998-02-18 1999-02-18 Treating cancer
JP2000532728A JP2002504354A (en) 1998-02-18 1999-02-18 Cancer Treatment
PCT/GB1999/000501 WO1999042835A1 (en) 1998-02-18 1999-02-18 Treating cancer
DE69907152T DE69907152D1 (en) 1998-02-18 1999-02-18 CANCER TREATMENT
JP2000532726A JP2002504496A (en) 1998-02-18 1999-02-18 Cancer Treatment
AU25380/99A AU739001B2 (en) 1998-02-18 1999-02-18 Treating cancer
CA002321482A CA2321482A1 (en) 1998-02-18 1999-02-18 Treating cancer
PCT/GB1999/000512 WO1999042839A2 (en) 1998-02-18 1999-02-18 Treating cancer
EP99905081A EP1057027A2 (en) 1998-02-18 1999-02-18 Treating cancer
DE69907156T DE69907156T2 (en) 1998-02-18 1999-02-18 CANCER TREATMENT
DE69907151T DE69907151D1 (en) 1998-02-18 1999-02-18 CANCER TREATMENT
CA002321479A CA2321479A1 (en) 1998-02-18 1999-02-18 Treating cancer
AT99905086T ATE238556T1 (en) 1998-02-18 1999-02-18 CANCER TREATMENT
EP99905086A EP1057031B1 (en) 1998-02-18 1999-02-18 Treating cancer
AU25385/99A AU753588B2 (en) 1998-02-18 1999-02-18 Treating cancer
CA002321438A CA2321438A1 (en) 1998-02-18 1999-02-18 Treating cancer
EP99906326A EP1057033B1 (en) 1998-02-18 1999-02-18 Treating cancer
PCT/GB1999/000509 WO1999042837A1 (en) 1998-02-18 1999-02-18 Treating cancer
JP2000532719A JP2002504353A (en) 1998-02-18 1999-02-18 Cancer Treatment
AU25379/99A AU743454B2 (en) 1998-02-18 1999-02-18 Treating cancer
AT99905082T ATE238553T1 (en) 1998-02-18 1999-02-18 CANCER TREATMENT
AU25384/99A AU741632B2 (en) 1998-02-18 1999-02-18 Treating cancer
JP2000532712A JP2002504683A (en) 1998-02-18 1999-02-18 Cancer Treatment
AU26300/99A AU749180B2 (en) 1998-02-18 1999-02-18 Treating cancer
AT99906326T ATE238558T1 (en) 1998-02-18 1999-02-18 CANCER TREATMENT
CA002321481A CA2321481A1 (en) 1998-02-18 1999-02-18 Treating cancer
AT99905087T ATE238557T1 (en) 1998-02-18 1999-02-18 CANCER TREATMENT
AU25382/99A AU741712B2 (en) 1998-02-18 1999-02-18 Treating cancer
PCT/GB1999/000503 WO1999042828A2 (en) 1998-02-18 1999-02-18 Treating cancer
EP99905087A EP1057032B1 (en) 1998-02-18 1999-02-18 Treating cancer
DE69907155T DE69907155T2 (en) 1998-02-18 1999-02-18 CANCER TREATMENT
DE69907153T DE69907153T2 (en) 1998-02-18 1999-02-18 CANCER TREATMENT
AT99905084T ATE238555T1 (en) 1998-02-18 1999-02-18 CANCER TREATMENT
US09/622,277 US6521407B1 (en) 1998-02-18 1999-02-18 Methods for determining chemosensitivity of cancer cells based upon expression of negative and positive signal transduction factors
PCT/GB1999/000506 WO1999042821A2 (en) 1998-02-18 1999-02-18 Treating cancer
JP2000532725A JP2002504687A (en) 1998-02-18 1999-02-18 Cancer Treatment
JP2000532107A JP2002503822A (en) 1998-02-18 1999-02-18 Cancer Treatment
PCT/GB1999/000505 WO1999042836A1 (en) 1998-02-18 1999-02-18 Treating cancer
AT99905083T ATE238554T1 (en) 1998-02-18 1999-02-18 CANCER TREATMENT
AU25381/99A AU735896B2 (en) 1998-02-18 1999-02-18 Treating cancer
EP99905084A EP1057030B1 (en) 1998-02-18 1999-02-18 Treating cancer
US10/321,555 US20030134315A1 (en) 1998-02-18 2002-12-18 Treating cancer

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB9803446A GB2334577A (en) 1998-02-18 1998-02-18 Resistance of p53 mutant cancer cells to cytoxic effects of (chemo)therapeutic agents involving assay of cyclin D1 protein

Publications (2)

Publication Number Publication Date
GB9803446D0 true GB9803446D0 (en) 1998-04-15
GB2334577A GB2334577A (en) 1999-08-25

Family

ID=10827211

Family Applications (1)

Application Number Title Priority Date Filing Date
GB9803446A Withdrawn GB2334577A (en) 1998-02-18 1998-02-18 Resistance of p53 mutant cancer cells to cytoxic effects of (chemo)therapeutic agents involving assay of cyclin D1 protein

Country Status (1)

Country Link
GB (1) GB2334577A (en)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1282815A2 (en) * 2000-05-12 2003-02-12 Prolifix Limited Assay for cell cycle modulators
CA2489726A1 (en) * 2002-06-18 2003-12-24 Irm Llc Diagnosis and treatment of chemoresistant tumors
CN110196327B (en) * 2019-05-18 2022-04-29 贵州医科大学附属医院 Kit for detecting drug sensitivity of rectal cancer cells based on gene variation analysis

Also Published As

Publication number Publication date
GB2334577A (en) 1999-08-25

Similar Documents

Publication Publication Date Title
GB2340945B (en) Measuring energy consumption
HK1022234A1 (en) Resistance element
GB2342863B (en) Probe
GB2343996B (en) Current sensing resistor
GB9821164D0 (en) Measuring device
GB9827147D0 (en) Meter interface
GB9803446D0 (en) Measuring resistance to chemotherapeutic agents
AU137974S (en) Measuring funnel
GB2337006B (en) Pocket Gym
GB2353598B (en) Improvements in or relating to current measurement
GB9824325D0 (en) Displacement measurement
GB9926526D0 (en) Displacement measurement
GB9912080D0 (en) Direction indicator
IL124901A0 (en) Lung function measuring device
GB9812028D0 (en) Flow measurement
GB2356705B (en) Measuring ruler
GB9824486D0 (en) Displacement measurement
GB9824485D0 (en) Displacement measurement
GB9824484D0 (en) Displacement measurement
GB9727138D0 (en) Area resistance meter
TW388508U (en) Improved speed measuring ball
GB9819535D0 (en) Flow measurement
GB9802613D0 (en) Indicator
GB9815943D0 (en) Improved utility meters
GB9823769D0 (en) Level measurement

Legal Events

Date Code Title Description
WAP Application withdrawn, taken to be withdrawn or refused ** after publication under section 16(1)